ACADIA HEALTHCARE CO INC (ACHC) Stock Fundamental Analysis
NASDAQ:ACHC - Nasdaq - US00404A1097 - Common Stock - Currency: USD
ACHC gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. ACHC has a medium profitability rating, but doesn't score so well on its financial health evaluation. ACHC has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
ACHC had positive earnings in the past year.
ACHC had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ACHC reported negative net income in multiple years.
Each year in the past 5 years ACHC had a positive operating cash flow.
1.2 Ratios
ACHC has a Return On Assets of 3.05%. This is in the better half of the industry: ACHC outperforms 63.73% of its industry peers.
ACHC has a Return On Equity of 6.17%. This is in the better half of the industry: ACHC outperforms 62.75% of its industry peers.
ACHC has a Return On Invested Capital of 6.43%. This is in the better half of the industry: ACHC outperforms 66.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ACHC is in line with the industry average of 9.53%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.05% | ||
| ROE | 6.17% | ||
| ROIC | 6.43% |
ROA(3y)3.12%
ROA(5y)0.6%
ROE(3y)5.75%
ROE(5y)-2.11%
ROIC(3y)7.93%
ROIC(5y)7.15%
1.3 Margins
ACHC's Profit Margin of 5.94% is amongst the best of the industry. ACHC outperforms 81.37% of its industry peers.
ACHC's Profit Margin has improved in the last couple of years.
ACHC's Operating Margin of 14.95% is amongst the best of the industry. ACHC outperforms 88.24% of its industry peers.
ACHC's Operating Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.95% | ||
| PM (TTM) | 5.94% | ||
| GM | N/A |
OM growth 3Y-1.13%
OM growth 5Y1.15%
PM growth 3Y-0.53%
PM growth 5Y8.37%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
ACHC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ACHC has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ACHC has been increased compared to 5 years ago.
ACHC has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.30, we must say that ACHC is in the distress zone and has some risk of bankruptcy.
ACHC has a Altman-Z score of 1.30. This is in the lower half of the industry: ACHC underperforms 66.67% of its industry peers.
ACHC has a Debt/Equity ratio of 0.72. This is a neutral value indicating ACHC is somewhat dependend on debt financing.
The Debt to Equity ratio of ACHC (0.72) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.72 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.3 |
ROIC/WACC0.78
WACC8.26%
2.3 Liquidity
A Current Ratio of 1.35 indicates that ACHC should not have too much problems paying its short term obligations.
ACHC has a Current ratio of 1.35. This is comparable to the rest of the industry: ACHC outperforms 41.18% of its industry peers.
ACHC has a Quick Ratio of 1.34. This is a normal value and indicates that ACHC is financially healthy and should not expect problems in meeting its short term obligations.
ACHC has a Quick ratio (1.34) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.35 | ||
| Quick Ratio | 1.34 |
3. Growth
3.1 Past
ACHC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.75%.
The Earnings Per Share has been growing by 10.21% on average over the past years. This is quite good.
The Revenue has been growing slightly by 5.48% in the past year.
The Revenue has been growing by 9.45% on average over the past years. This is quite good.
EPS 1Y (TTM)-18.75%
EPS 3Y8.69%
EPS 5Y10.21%
EPS Q2Q%-52.38%
Revenue 1Y (TTM)5.48%
Revenue growth 3Y10.87%
Revenue growth 5Y9.45%
Sales Q2Q%0.32%
3.2 Future
ACHC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.70% yearly.
The Revenue is expected to grow by 8.58% on average over the next years. This is quite good.
EPS Next Y-17.88%
EPS Next 2Y-3.75%
EPS Next 3Y0.17%
EPS Next 5Y3.7%
Revenue Next Year5.59%
Revenue Next 2Y7.06%
Revenue Next 3Y7.27%
Revenue Next 5Y8.58%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
ACHC is valuated reasonably with a Price/Earnings ratio of 8.03.
Based on the Price/Earnings ratio, ACHC is valued cheaply inside the industry as 96.08% of the companies are valued more expensively.
ACHC's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.91.
With a Price/Forward Earnings ratio of 7.51, the valuation of ACHC can be described as very cheap.
Based on the Price/Forward Earnings ratio, ACHC is valued cheaper than 93.14% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.85, ACHC is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.03 | ||
| Fwd PE | 7.51 |
4.2 Price Multiples
ACHC's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ACHC is cheaper than 87.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 6.76 |
4.3 Compensation for Growth
The decent profitability rating of ACHC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.79
EPS Next 2Y-3.75%
EPS Next 3Y0.17%
5. Dividend
5.1 Amount
ACHC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
22.96
-0.55 (-2.34%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners109.62%
Inst Owner Change-0.19%
Ins Owners1%
Ins Owner Change6.48%
Market Cap2.12B
Analysts83.16
Price Target47.31 (106.05%)
Short Float %9.25%
Short Ratio3.05
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.13%
Min EPS beat(2)-12.21%
Max EPS beat(2)9.95%
EPS beat(4)2
Avg EPS beat(4)-0.27%
Min EPS beat(4)-12.21%
Max EPS beat(4)9.95%
EPS beat(8)6
Avg EPS beat(8)1.47%
EPS beat(12)9
Avg EPS beat(12)9.78%
EPS beat(16)11
Avg EPS beat(16)7.83%
Revenue beat(2)0
Avg Revenue beat(2)-2.22%
Min Revenue beat(2)-2.56%
Max Revenue beat(2)-1.88%
Revenue beat(4)0
Avg Revenue beat(4)-1.84%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)-0.51%
Revenue beat(8)3
Avg Revenue beat(8)-1.06%
Revenue beat(12)4
Avg Revenue beat(12)-0.9%
Revenue beat(16)5
Avg Revenue beat(16)-0.8%
PT rev (1m)-2.27%
PT rev (3m)-24.06%
EPS NQ rev (1m)-2.11%
EPS NQ rev (3m)-17.44%
EPS NY rev (1m)0.09%
EPS NY rev (3m)-20.78%
Revenue NQ rev (1m)-0.66%
Revenue NQ rev (3m)-2.22%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-3.21%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.03 | ||
| Fwd PE | 7.51 | ||
| P/S | 0.67 | ||
| P/FCF | N/A | ||
| P/OCF | 4.57 | ||
| P/B | 0.7 | ||
| P/tB | 3.08 | ||
| EV/EBITDA | 6.76 |
EPS(TTM)2.86
EY12.46%
EPS(NY)3.06
Fwd EY13.32%
FCF(TTM)-2.82
FCFYN/A
OCF(TTM)5.02
OCFY21.86%
SpS34.26
BVpS33.01
TBVpS7.45
PEG (NY)N/A
PEG (5Y)0.79
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.05% | ||
| ROE | 6.17% | ||
| ROCE | 8.32% | ||
| ROIC | 6.43% | ||
| ROICexc | 6.54% | ||
| ROICexgc | 11.31% | ||
| OM | 14.95% | ||
| PM (TTM) | 5.94% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)3.12%
ROA(5y)0.6%
ROE(3y)5.75%
ROE(5y)-2.11%
ROIC(3y)7.93%
ROIC(5y)7.15%
ROICexc(3y)8.08%
ROICexc(5y)7.37%
ROICexgc(3y)16.06%
ROICexgc(5y)14.72%
ROCE(3y)10.25%
ROCE(5y)9.25%
ROICexcg growth 3Y-4.56%
ROICexcg growth 5Y16.02%
ROICexc growth 3Y1.65%
ROICexc growth 5Y14.56%
OM growth 3Y-1.13%
OM growth 5Y1.15%
PM growth 3Y-0.53%
PM growth 5Y8.37%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.72 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.46 | ||
| Cap/Depr | 450.84% | ||
| Cap/Sales | 22.89% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 73.16% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.35 | ||
| Quick Ratio | 1.34 | ||
| Altman-Z | 1.3 |
F-Score6
WACC8.26%
ROIC/WACC0.78
Cap/Depr(3y)344.44%
Cap/Depr(5y)299.77%
Cap/Sales(3y)15.9%
Cap/Sales(5y)13.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.75%
EPS 3Y8.69%
EPS 5Y10.21%
EPS Q2Q%-52.38%
EPS Next Y-17.88%
EPS Next 2Y-3.75%
EPS Next 3Y0.17%
EPS Next 5Y3.7%
Revenue 1Y (TTM)5.48%
Revenue growth 3Y10.87%
Revenue growth 5Y9.45%
Sales Q2Q%0.32%
Revenue Next Year5.59%
Revenue Next 2Y7.06%
Revenue Next 3Y7.27%
Revenue Next 5Y8.58%
EBIT growth 1Y-9.84%
EBIT growth 3Y9.61%
EBIT growth 5Y10.7%
EBIT Next Year24.74%
EBIT Next 3Y13.4%
EBIT Next 5Y11.46%
FCF growth 1Y-820.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y32.81%
OCF growth 3Y-29.78%
OCF growth 5Y-15.9%